CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Context Therapeutics Inc.

CNTX
$34MMicro Cap

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for CNTX. That does not mean none is planned.

Get an email about CNTX's next catalysts

Track Context Therapeutics (CNTX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Catalyst Timeline

0 upcoming, 2 past

No catalysts found.

Market Overview

Stock performance and key metrics

NASDAQPharmaceutical PreparationsπŸ‡ΊπŸ‡ΈNorth AmericaPHILADELPHIA12 employees
Drug Pipeline

Frequently asked questions

What is in Context Therapeutics Inc.'s drug pipeline?β†’

CatalystAlert tracks 3 drug candidates in Context Therapeutics Inc.'s (CNTX) pipeline across Phase 2. Its lead program is Extended-release Onapristone (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Context Therapeutics Inc.'s next FDA catalyst?β†’

CatalystAlert tracks every upcoming catalyst for Context Therapeutics Inc. (CNTX) β€” PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β€” each confidence-rated as confirmed, estimated or AI-detected.

How do I track CNTX biotech catalysts?β†’

Add CNTX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Context Therapeutics Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply